Design of artificial nucleobases for the recognition of the AT inversion by triple-helix forming oligonucleotides: A structure-stability relationship study and neighbour bases effect

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 13, 2003, Pages 2751-2759

  Guianvarc'h, Dominique ^a   Fourrey, Jean Louis ^b   Maurisse, Rosalie ^a   Sun, Jian Sheng ^a   Benhida, Rachid ^b,c  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b CNRS   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID BASE; OLIGONUCLEOTIDE; PYRIMIDINE;

ARTICLE; BASE PAIRING; PROTEIN ANALYSIS; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; TRIPLE HELIX;

EID: 0038143610     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00229-3     Document Type: Article

References (46)

1. The symbols · and x indicate Watson-Crick and Hoogsteen hydrogen bonds, respectively.
2. (a) Le Doan T., Perrouault L., Praseuth D., Habhoub N., Decout J.L., Thuong N.T., Lhomme J., Hélène C. Nucleic Acids Res. 15:1987;7749.
3. (b) Moser H.E., Dervan P.B. Science. 238:1987;645.
4. (c). For reviews see: Thuong N.T., Hélène C. Angew. Chem., Int. Ed. Engl. 32:1993;666.
5. (d) Frank-Kamenetskii M.T., Mirkin S.M. Annu. Rev. Biochem. 64:1995;65.
6. (e) Neidle S. Anti-Cancer Drug Des. 12:1997;433.
7. (a) Maher J.L. III Cancer Invest. 14:1996;66.
8. (b) Giovannangeli C., Hélène C. Antisense Nucleic Acid Drug Dev. 7:1997;413.
9. (c) Vasquez K.M., Wilson J.H. Trends Biochem. Sci. 23:1998;4.
10. (d) Praseuth D., Guieysse-Peugeot A.L., Hélène C. Biochim. Biophys. Acta. 1489:1999;181.
11. (a) Mergny J.L., Sun J.S., Rougée M., Garestier T., Barcelo F., Chomilier J., Hélène C. Biochemistry. 30:1991;9791.
12. (b) Greenberg W.A., Dervan P.B. J. Am. Chem. Soc. 117:1995;5016.
13. (c) Best G.C., Dervan P.B. J. Am. Chem. Soc. 117:1995;1187.
14. Reviews:(a) Sun J.S., Hélène C. Cur. Opin. Struct. Biol. 3:1993;345 (b) Doronina S.O., Behr J.P. Chem. Soc. Rev. 1997;63 (c) Gowers D.M., Fox K.R. Nucleic Acids Res. 27:1999;1569. and references cited therein.
15. Reviews:(a) Sun J.S., Hélène C. Cur. Opin. Struct. Biol. 3:1993;345 (b) Doronina S.O., Behr J.P. Chem. Soc. Rev. 1997;63 (c) Gowers D.M., Fox K.R. Nucleic Acids Res. 27:1999;1569. and references cited therein.
16. Reviews:(a) Sun J.S., Hélène C. Cur. Opin. Struct. Biol. 3:1993;345 (b) Doronina S.O., Behr J.P. Chem. Soc. Rev. 1997;63 (c) Gowers D.M., Fox K.R. Nucleic Acids Res. 27:1999;1569. and references cited therein.
17. (a) Griffin L.C., Kiessling L.L., Beal P.A., Gillespie P., Dervan P.B. J. Am. Chem. Soc. 114:1992;7976.
18. (b) Koshlap K.M., Gillespie P., Dervan P.B., Feigon J. J. Am. Chem. Soc. 115:1993;7908.
19. (c) Huang C.Y., Cushman C.D., Miller P.S. J. Org. Chem. 58:1993;5048.
20. (d) Huang C.Y., Miller P.S. J. Am. Chem. Soc. 15:1993;10456.
21. (e) Huang C.Y., Bi G., Miller P.S. Nucleic Acids Res. 24:1996;2606.
22. (f) Lehmann T.E., Greenberg W.A., Liberles D.A., Wada C.K., Dervan P.B. Helv. Chim. Acta. 80:1997;2002.
23. (a) Durland R.H., Rao T.S., Bodepudi V., Seth D.M., Jayaraman K., Revankar G.R. Nucleic Acids Res. 23:1995;647.
24. (b) Zhou B., Puga E., Sun J.S., Garestier T., Hélène C. J. Am. Chem. Soc. 117:1995;10425
25. (c) Kukreti S., Sun J.S., Garestier T., Hélène C. Nucleic Acids Res. 25:1997;4264
26. (d) Kukreti S., Sun J.S., Loakes D., Brown D.M., Nguyen C.H., Bisagni E., Garestier T., Hélène C. Nucleic Acids Res. 26:1998;2179
27. (e) Gianolio D.A., McLaughlin L.W. J. Am. Chem. Soc. 121:1999;6334.
28. Communications:(a) Guianvarc'h D., Benhida R. Fourrey, J-L., Maurisse, R. and Sun, J. S., Chem. Commun. 2001;1814 (b) Guianvarc'h D., Fourrey J.-L., Maurisse R., Sun J.S., Benhida R. Org. Lett. 4:2002;4209.
29. Communications:(a) Guianvarc'h D., Benhida R. Fourrey, J-L., Maurisse, R. and Sun, J. S., Chem. Commun. 2001;1814 (b) Guianvarc'h D., Fourrey J.-L., Maurisse R., Sun J.S., Benhida R. Org. Lett. 4:2002;4209.
30. (a) Basha A., Lipton M., Weinreb S.M. Tetrahedron Lett. 48:1977;4171
31. (b) Lipton M.F., Basha A., Weinreb M. Org. Synth. 59:1979;49.
32. Hovinen J., Salo H. J. Chem. Soc., Perkin Trans. 1. 1997;3017.
33. Benhida R., Lecubin F., Fourrey J.-L., Quintero L. Tetrahedron Lett. 40:1999;5701.
34. (a) Stille J.K. J. Am. Chem. Soc. 1979;4992
35. (b) Stille J.K. Angew. Chem., Int. Ed. Engl. 25:1986;508.
36. Compound 5 was obtained in three steps from 2-aminothiazole (see ref 8b).
37. Hoffer M. Chem. Ber. 93:1960;2777.
38. 2O leading to a 1:3 mixture of α/β anomers in 90% yield.
39. Mukayiama T., Usui M., Shimada E., Saigo K. Chem. Lett. 1975;1045.
40. 2 and 0.5 mM spermine.
41. Kiessling L.L., Griffin L.C., Dervan P.B. Biochemistry. 31:1992;2829.
42. (a) NMR structural studies of the A·TxG triplet have explained this stabilization by the existence of a favourable stacking interaction between guanine (of the triplet A·TxG) and the thymine on the 5′-side (Radhakrishnan, I.; Gao, X.; De Los Santos, C.; Live, D.; Patel, D. J. Biochemistry 1991, 30, 9022).
43. 2 when Z=S.
44. (a) NMR structural studies of the A·TxG triplet have explained this stabilization by the existence of a favourable stacking interaction between guanine (of the triplet A·TxG) and the thymine on the 5′-side (Radhakrishnan, I.; Gao, X.; De Los Santos, C.; Live, D.; Patel, D. J. Biochemistry 1991, 30, 9022).
45. 2 when Z=S.
46. 3 to be intercalated between the A·T inverted base pair and the 3′ neighbouring triplet thus explaining the 3′ neighbour effect (Koshlap, K.M.; Gillespie, P.; Dervan, P.B.; Feigon, J. J. Am. Chem. Soc. 1993, 115, 7908). In the case of S, this absence of 3′ or 5′ effect seems to be in favour of a recognition process which involves hydrogen bond contacts.